-
1
-
2
-
3Academic Journal
Authors: Nurmetova Farida Ortiq qizi
-
4Academic Journal
-
5Academic Journal
-
6Academic Journal
Source: Байкальский медицинский журнал, Vol 3, Iss 4, Pp 40-49 (2024)
Subject Terms: омник, воспаление, противовоспалительное действие, Medicine (General), R5-920
File Description: electronic resource
-
7Academic Journal
Source: Eurasian Journal of Medical and Natural Sciences; Vol. 5 No. 11 (2025): Eurasian Journal of Medical and Natural Sciences; 37-42 ; Евразийский журнал медицинских и естественных наук; Том 5 № 11 (2025): Евразийский журнал медицинских и естественных наук; 37-42 ; Yevrosiyo tibbiyot va tabiiy fanlar jurnali; Jild 5 Nomeri 11 (2025): Евразийский журнал медицинских и естественных наук; 37-42 ; 2181-287X
Subject Terms: Ихтиоз, кератолитическое действие, противовоспалительное действие, регенативное действие, сухой экстракт, гелеобразователи, технология, оценка качества, Ichthyosis, keratolytic effect, anti-inflammatory effect, regenerative effect, dry extract, gelling agents, technology, quality assessment, Ixtio'zis, keratolitik ta'sir, yallig'lanishga qarshi ta'sir, regenerativ ta'sir, quruq ekstrakt, gelsimon, texnologiya, sifatni baholash
File Description: application/pdf
Availability: https://in-academy.uz/index.php/EJMNS/article/view/65423
-
8Academic Journal
Authors: Омонтошева, М. Т., Аюбов, Д.К., Файзуллаева , Н. С.
Source: Eurasian Journal of Medical and Natural Sciences; Vol. 5 No. 10 Part 2 (2025): Eurasian Journal of Medical and Natural Sciences; 134-142 ; Евразийский журнал медицинских и естественных наук; Том 5 № 10 Part 2 (2025): Евразийский журнал медицинских и естественных наук; 134-142 ; Yevrosiyo tibbiyot va tabiiy fanlar jurnali; Jild 5 Nomeri 10 Part 2 (2025): Евразийский журнал медицинских и естественных наук; 134-142 ; 2181-287X
Subject Terms: Аллергодерматоз, противовоспалительное действие, сухой экстракт, технологические показатели, технология, оценка качества, Allergic dermatosis, anti-inflammatory effect, dry extract, technological parameters, technology, quality assessment, Allegrodermatoz, yallig'lanishga qarshi ta'sir, quruq ekstrakt, texnologik ko'rsatkichlar, texnologiya, sifatni baholash
File Description: application/pdf
Availability: https://in-academy.uz/index.php/EJMNS/article/view/63941
-
9Academic Journal
Authors: Аманович, Маджидов Абдинаби
Source: TA'LIM VA RIVOJLANISH TAHLILI ONLAYN ILMIY JURNALI; Vol. 5 No. 1 (2025): TАЪЛИМ ВА РИВОЖЛАНИШ ТАҲЛИЛИ ОНЛАЙН ИЛМИЙ ЖУРНАЛИ; 81-85 ; 2181-2624
Subject Terms: Топинамбур, фармакологические свойства, инулин, антидиабетическое действие, противовоспалительное действие, гипотензивное действие, антиоксидантная активность
File Description: application/pdf
Relation: https://sciencebox.uz/index.php/ajed/article/view/13018/12581; https://sciencebox.uz/index.php/ajed/article/view/13018/12596; https://sciencebox.uz/index.php/ajed/article/view/13018
Availability: https://sciencebox.uz/index.php/ajed/article/view/13018
-
10Academic Journal
Authors: I. O. Smirnova, O. N. Smirnova, I. A. Fedorova, P. D. Ptashnikova, И. О. Смирнова, О. Н. Смирнова, И. А. Федорова, П. Д. Пташникова
Source: Meditsinskiy sovet = Medical Council; № 4 (2025); 53-58 ; Медицинский Совет; № 4 (2025); 53-58 ; 2658-5790 ; 2079-701X
Subject Terms: противовоспалительное действие, anogenital region, baseline therapy, skin barrier, dexpanthenol, glucocorticosteroids, treatment, pruritus, clinical manifestations, anti-inflammatory effect, аногенитальная область, базисная терапия, кожный барьер, декспантенол, глюкокортикостероиды, лечение, зуд
File Description: application/pdf
Relation: https://www.med-sovet.pro/jour/article/view/9024/7841; Lewin MR, Hick RW, Selim MA. Lichenoid Dermatitis of the Vulva: Diagnosis and Differential Diagnosis for the Gynecologic Pathologist. Adv Anat Pathol. 2017;24(5):278–293. https://doi.org/10.1097/PAP.0000000000000160.; Day T, Mauskar M, Selk A (eds.). Lichen sclerosus: ISSVD practical guide to diagnosis and management. Ad Médic, Lda.; 2024. 212 p. https://doi.org/10.59153/adm.ls.001.; Hong JJ, Mosca ML, Hadeler EK, Brownstone ND, Bhutani T, Liao WJ. Genital and Inverse/Intertriginous Psoriasis: An Updated Review of Therapies and Recommendations for Practical Management. Dermatol Ther. 2021;11(3):833–844. https://doi.org/10.1007/s13555-021-00536-6.; Corazza M, Toni G, Virgili A, Borghi A. Plasma cell vulvitis: further confirmation of the diagnostic utility of dermoscopy. Int J Dermatol. 2018;57(12):e164-e165. https://doi.org/10.1111/ijd.14233.; Yeung J, Pauls RN. Anatomy of the Vulva and the Female Sexual Response. Obstet Gynecol Clin North Am. 2016;43(1):27–44. https://doi.org/10.1016/j.ogc.2015.10.011.; Смирнова ИО (ред.). Неинфекционные дерматозы вульвы: диагностика, лечение: иллюстрированное руководство для врачей. М.: ГЭОТАР-Медиа; 2021. 240 с. https://doi.org/10.33029/9704-6008-5-NDV-1-240.; Nunns D, Mandal D. The chronically symptomatic vulva: prevalence in primary health care. Genitourin Med. 1996;72(5):343–344. https://doi.org/10.1136/sti.72.5.343.; Raef HS, Elmariah SB. Vulvar Pruritus: A Review of Clinical Associations, Pathophysiology and Therapeutic Management. Front Med. 2021;8:649402. https://doi.org/10.3389/fmed.2021.649402.; Neill SM, Lewis FM, Tatnall FM, Cox NH; British Association of Dermatologists. British Association of Dermatologists’ guidelines for the management of lichen sclerosus 2010. Br J Dermatol. 2010;163(4):672–682. https://doi.org/10.1111/j.1365-2133.2010.09997.x.; Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018;32(5):657–682. https://doi.org/10.1111/jdv.14891.; Lifits-Podorozhansky YM, Podorozhansky Y, Hoffstetter S, Gavard JA. Role of vulvar care guidelines in the initial management of vulvar complaints. J Low Genit Tract Dis. 2012;16(2):88–91. https://doi.org/10.1097/LGT.0b013e318232fd9a.; Lagro-Janssen AL, Sluis S. Effectiveness of treating non-specific pruritus vulvae with topical steroids: a randomized controlled trial. Eur J Gen Pract. 2009;15(1):29–33. https://doi.org/10.1080/13814780802705976.; Biro K, Thaçi D, Ochsendorf FR, Kaufmann R, Boehncke WH. Efficacy of dexpanthenol in skin protection against irritation: a double-blind, placebocontrolled study. Contact Dermatitis. 2003;49(2):80–84. https://doi.org/10.1111/j.0105-1873.2003.00184.x.; Proksch E, de Bony R, Trapp S, Boudon S. Topical use of dexpanthenol: a 70th anniversary article. J Dermatolog Treat. 2017;28(8):766–773. https://doi.org/10.1080/09546634.2017.1325310.; Мурашкин НН, Материкин АИ, Епишев РВ, Амбарчян ЭТ. Особенности течения и профилактики пеленочного дерматита у новорожденных и детей грудного возраста. Вопросы современной педиатрии. 2015;14(6):710–713. https://doi.org/10.15690/vsp.v14i6.1481.; Peltier E, de Salvo R, Ehret A, Trapp S, Lakomsky D, El Shazly MA. Evaluation of a 5% dexpanthenol-containing ointment for the treatment of infant irritant diaper dermatitis through the lens of the caregiver-A real-world data observational study. Health Sci Rep. 2023;6(1):e1033. https://doi.org/10.1002/hsr2.1033.; Abiko Y, Tomikawa M, Shimizu M. Enzymatic conversion of pantothenylalcohol to pantothenic acid. J Vitaminol. 1969;15(1):59–69. https://doi.org/10.5925/jnsv1954.15.59.; Hrubša M, Siatka T, Nejmanová I, Vopršalová M, Kujovská Krčmová L, Matoušová K et al. Biological Properties of Vitamins of the B-Complex, Part 1: Vitamins B1 , B2 , B3 , and B5 . Nutrients. 2022;14(3):484. https://doi.org/10.3390/nu14030484.; Williams RJ, Saunders DH. The effects of inositol, crystalline vitamin B(1) and “pantothenic acid” on the growth of different strains of yeast. Biochem J. 1934;28(5):1887–1893. https://doi.org/10.1042/bj0281887.; Ebner F, Heller A, Rippke F, Tausch I. Topical use of dexpanthenol in skin disorders. Am J Clin Dermatol. 2002;3(6):427–433. https://doi.org/10.2165/00128071-200203060-0000; Proksch E, Berardesca E, Misery L, Engblom J, Bouwstra J. Dry skin management: practical approach in light of latest research on skin structure and function. J Dermatolog Treat. 2020;31(7):716–722. https://doi.org/10.1080/09546634.2019.1607024.; Stettler H, Kurka P, Lunau N, Manger C, Böhling A, Bielfeldt S et al. A new topical panthenol-containing emollient: Results from two randomized controlled studies assessing its skin moisturization and barrier restoration potential, and the effect on skin microflora. J Dermatolog Treat. 2017;28(2):173–180. https://doi.org/10.1080/09546634.2016.1214235.; Björklund S, Pham QD, Jensen LB, Knudsen NØ, Nielsen LD, Ekelund K et al. The effects of polar excipients transcutol and dexpanthenol on molecular mobility, permeability, and electrical impedance of the skin barrier. J Colloid Interface Sci. 2016;479:207–220. https://doi.org/10.1016/j.jcis.2016.06.054.; Stettler H, Kurka P, Wagner C, Sznurkowska K, Czernicka O, Böhling A, et al. A new topical panthenol-containing emollient: skin-moisturizing effect following single and prolonged usage in healthy adults, and tolerability in healthy infants. J Dermatolog Treat. 2017;28(3):251–257. https://doi.org/10.1080/09546634.2016.1218417.; Udompataikul M, Limpa-o-vart D. Comparative trial of 5% dexpanthenol in water-in-oil formulation with 1% hydrocortisone ointment in the treatment of childhood atopic dermatitis: a pilot study. J Drugs Dermatol. 2012;11(3):366–374. Available at: https://pubmed.ncbi.nlm.nih.gov/22395588.; Огородова ЛМ, Нагаева ТА, Ходкевич ЛВ. Эффективность декспантенола в комплексном лечении атопического дерматита у детей. Педиатрическая фармакология. 2003;1(3):54–56. Режим доступа: https://cyberleninka.ru/article/n/effektivnost-dekspantenola-v-kompleksnom-lecheniiatopicheskogo-dermatita-u-detey/viewer.; Кубанов АА, Аполихина ИА, Плахова КИ, Чернова НИ, Соколова АВ. Лишай склеротический и атрофический: клинические рекомендации. 2020.; Духанин АС. Водородный показатель (рН) основы топического лекарственного препарата: выбор оптимального значения и роль буферной системы. Клиническая дерматология и венерология. 2016;15(2):47-52. https://doi.org/10.17116/klinderma201615247-52.; Устинов МВ. Эмпирическая терапия воспалительных поражений кожи крупных складок. РМЖ. 2016;(14):945–948. Режим доступа: https://www.rmj.ru/articles/dermatologiya/Empiricheskaya_terapiya_vospalitelynyh_poragheniy_koghi_krupnyh_skladok.; Macura AB. In vitro susceptibility of dermatophytes to antifungal drugs: a comparison of two methods. Int J Dermatol. 1993;32(7):533–536. https://doi.org/10.1111/j.1365-4362.1993.tb02844.x.; Arévalo MP, Carrillo-Muñoz AJ, Salgado J, Cardenes D, Brió S, Quindós G, Espinel-Ingroff A. Antifungal activity of the echinocandin anidulafungin (VER002, LY-303366) against yeast pathogens: a comparative study with M27-A microdilution method. J Antimicrob Chemother. 2003;51(1):163–166. https://doi.org/10.1093/jac/dkg018.
-
11Academic Journal
Source: Рецепт. :67-77
Subject Terms: 0301 basic medicine, calendula officinalis, 0303 health sciences, окопник лекарственный, наружные лекарственные формы, лекарственные растения, лекарственное растительное сырье, полынь горькая, yarrow, календула лекарственная, external dosage forms, anti- inflammatory effect, St. John's wort, medicinal herbal raw materials, 3. Good health, тысячелистник обыкновенный, 03 medical and health sciences, противовоспалительное действие, comfrey officinalis, зверобой продырявленный, wormwood, medicinal plants
-
12Academic Journal
Authors: Kapelka, I. G., Shtrygol’, S. Yu.
Source: News of Pharmacy; № 2(100) (2020); 106-112
Вестник фармации; № 2(100) (2020); 106-112
Вісник фармації; № 2(100) (2020); 106-112Subject Terms: 03 medical and health sciences, 0404 agricultural biotechnology, 0302 clinical medicine, воспаление, модель, каррагенин, противовоспалительное действие, диклофенак натрия, гипотермия, УДК: 616-002.3:615.276:615.015.16:616-001.18, запалення, карагенін, протизапальна дія, диклофенак натрію, гіпотермія, UDC: 616-002.3:615.276:615.015.16:616-001.18, inflammation, model, carrageenan, anti-inflammatory action, sodium diclofenac, hypothermia, 04 agricultural and veterinary sciences, 3. Good health
File Description: application/pdf
-
13Academic Journal
Source: Clinical pharmacy; Vol. 24 No. 3 (2020); 53-59
Клиническая фармация; Том 24 № 3 (2020); 53-59
Клінічна фармація; Том 24 № 3 (2020); 53-59
Клінічна фармація; Том 24, № 3 (2020); 53-59
Clinical pharmacy; Том 24, № 3 (2020); 53-59
Клиническая фармация; Том 24, № 3 (2020); 53-59Subject Terms: анальгетическое действие, UDC 615.276:582.284.56, Phallus impudicus tincture, gastroprotective effect, anti-inflammatory effect, analgesic effect, 582.284.56, УДК 615.276:582.284.56, настойка гриба веселки, гастропротекторна дія, протизапальна дія, аналгетична дія, UDC 615.276, гастропротекторное действие, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, противовоспалительное действие, УДК 615.276
File Description: application/pdf
-
14Academic Journal
Authors: T. L. Pilat, L. P. Kuzmina, E. L. Lashina, M. M. Kolyaskina, L. M. Bezrukavnikova, V. V. Bessonov, M. M. Korosteleva, K. G. Gurevich, N. P. Lagutina, R. A. Khanferyan
Source: Медицинский совет, Vol 0, Iss 4, Pp 107-113 (2020)
Subject Terms: Specialized product, 0301 basic medicine, 2. Zero hunger, 0303 health sciences, plant extracts, диетическое и лечебное питание, Anti-inflammatory effect, Plant extracts, специализированный продукт, 3. Good health, serum protein concentration, 03 medical and health sciences, Serum protein concentration, противовоспалительное действие, specialized product, anti-inflammatory effect, растительные экстракты, Dietary and therapeutic nutrition, Medicine, протеинограмма, dietary and therapeutic nutrition
Access URL: https://www.med-sovet.pro/jour/article/download/5618/5118
https://doaj.org/article/d8e94bcb25f8445098383acd1f87293a
https://cyberleninka.ru/article/n/opyt-primeneniya-spetsializirovannogo-pischevogo-produkta-dieticheskogo-lechebnogo-i-dieticheskogo-profilakticheskogo-pitaniya-pri
https://www.med-sovet.pro/jour/article/viewFile/5618/5118
https://cyberleninka.ru/article/n/opyt-primeneniya-spetsializirovannogo-pischevogo-produkta-dieticheskogo-lechebnogo-i-dieticheskogo-profilakticheskogo-pitaniya-pri/pdf
https://www.med-sovet.pro/jour/article/view/5618 -
15Academic Journal
Authors: Oleinik, I.S., Bibik, E.Yu., Dotsenko, V.V., Strelkov, V.D., Lukina, D.Yu., Frolov, К.A., Krivokolysko, S.G., Vasilin, V.K.
Subject Terms: антиэкссудативная активность, formalin induced edema, 1,4-dihydronicotinamides, 1,4-дигидро-никотинамиды, виртуальный биоскрининг, присоединение по Михаэлю, virtual bioscreening, УДК 547.822.1, противовоспалительное действие, anti-inflammatory effect, Michael addition, anti-exudative activity, cyanothioacetamide, УДК 547.825, формалиновый отек, цианотиоацетамид
File Description: application/pdf
-
16Academic Journal
Authors: A. S. Stadnikova, G. A. Novik, G. E. Bagramova, A. S. Vorobeva, А. С. Стадникова, Г. А. Новик, Г. Э. Баграмова, А. С. Воробьева
Source: Meditsinskiy sovet = Medical Council; № 2 (2023); 105-112 ; Медицинский Совет; № 2 (2023); 105-112 ; 2658-5790 ; 2079-701X
Subject Terms: стероидсберегающий эффект, topical calcineurin inhibitors, Tacrolimus, barrier function, skin, anti-inflammatory effect, steroidsparing effect, топические ингибиторы кальциневрина, такролимус, барьерная функция, кожа, противовоспалительное действие
File Description: application/pdf
Relation: https://www.med-sovet.pro/jour/article/view/7395/6596; Глухова Е.А., Мухортых В.А., Тамразова О.Б., Таганов А.В., Ревякина В.А. Предикторы тяжелого течения атопического дерматита. Вопросы питания. 2022;91(1):76–85. https://doi.org/10.33029/0042-8833-2022-91-1-76-85.; Siegfried E.C., Jaworski J.C., Kaiser J.D., Hebert A.A. Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis. BMC Pediatr. 2016;(16):75. https://doi.org/10.1186/s12887-016-0607-9.; Mancini A.J., Kaulback K., Chamlin S.L. The socioeconomic impact of atopic dermatitis in the United States: a systematic review. Pediatr Dermatol. 2008;25(1):1–6. https://doi.org/10.1111/j.1525-1470.2007.00572.x.; Kim J.P., Chao L.X., Simpson E.L., Silverberg J.I. Persistence of atopic dermatitis (AD): a systematic review and meta-analysis. J Am Acad Dermatol. 2016;75(4):681–687. https://doi.org/10.1016/j.jaad.2016.05.028.; Boguniewicz M., Fonacier L., Guttman-Yassky E., Ong P.Y., Silverberg J., Farrar J.R. Atopic dermatitis yardstick: practical recommendations for an evolving therapeutic landscape. Ann Allergy Asthma Immunol. 2018;120(1):10–22.e2. https://doi.org/10.1016/j.anai.2017.10.039.; Sayaseng K.Y., Vernon P. Pathophysiology and management of mild to moderate pediatric atopic dermatitis. J Pediatr Health Care. 2018;32(2):S2–S12. https://doi.org/10.1016/j.pedhc.2017.10.002.; Pustišek N., Živković M.V., Šitum M. Quality of life in fami lies with children with atopic dermatitis. Pediatr Dermatol. 2016;33(1):28–32. https://doi.org/10.1111/pde.12698.; Kuo I.H., Yoshida T., De Benedetto A., Beck L.A. The cutaneous innate immune response in patients with atopic dermatitis. J Allergy Clin Immunol. 2013;131(2):266–278. https://doi.org/10.1016/j.jaci.2012.12.1563.; Boguniewicz M., Leung D.Y.M. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev. 2011;242(1):233–246. https://doi.org/10.1111/j.1600-065X.2011.01027.x.; Irvine A.D., Mclean W.H.I., Leung D.Y.M. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med. 2011;365(14):1315–1327. https://doi.org/10.1056/NEJMra1011040.; Wollenberg A., Barbarot S., Bieber T., Christen-Zaech S., Deleuran M., Fink-Wagner A. et al. Global Allergy and Asthma European Network (GA2LEN) and the European Union of Medical Specialists (UEMS) Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: Part I. J Eur Acad Dermatol Venereol. 2018;32(5):657–682. https://doi.org/10.1111/jdv.14891.; Eichenfield L.F., Tom W.L., Berger T.G., Krol A., Paller A.S., Schwarzenberg K. et al. Guidelines of care for the management of atopic dermatitis: Section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71(1):116–132. https://doi.org/10.1016/j.jaad.2014.03.023.; Kapur S., Watson W., Carr S. Atopic dermatitis. Allergy Asthma Clin Immunol. 2018;14(2):52. https://doi.org/10.1186/s13223-018-0281-6.; Rathi S.K., D’Souza P. Rational and ethical use of topical corticosteroids based on safety and efficacy. Indian J Dermatol. 2012;57(4):251–259. https://doi.org/10.4103/0019-5154.97655.; Hughes J., Rustin M. Corticosteroids. Clin Dermatol. 1997;15(5):715–721. https://doi.org/10.1016/s0738-081x(97)00020-5.; Charman C.R., Morris A.D., Williams H.C. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol. 2000;142(5):931–936. https://doi.org/10.1046/j.1365-2133.2000.03473.x; Nghiem P., Pearson G., Langley R.G. Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis. J Am Acad Dermatol. 2002;46(2):228–241. https://doi.org/10.1067/mjd.2002.120942.; Reitamo S. Tacrolimus: a topical immunomodulatory therapy for atopic dermatitis. J Allergy Clin Immunol. 2001;107(3):445–448. https://doi.org/10.1067/mai.2001.113521.; Santini M.P., Talora C., Seki T., Bolgan L., Dotto G.P. Cross talk among calcineurin, Sp1/Sp3, and NFAT in control of p21(WAF1/CIP1) expression in keratinocyte differentiation. Proc Natl Acad Sci USA. 2001;98(17):9575–9580. https://doi.org/10.1073/pnas.161299698.; Remitz A., Kyllönen H., Granlund H., Reitamo S. Tacrolimus ointment reduces staphylococcal colonization of atopic dermatitis lesions. J Allergy Clin Immunol. 2001;107(1):196–197. https://doi.org/10.1067/mai.2001.112131.; Boguniewicz M., Fiedler V.C., Raimer S., Lawrence I.D., Hanifin J.M. A randomized, vehicle controlled trial of tacrolimus ointment for the treatment of atopic dermatitis in children. J Allergy Clin Immunol. 1998;102(4):637–644. https://doi.org/10.1016/s0091-6749(98)70281-7.; Hanifin J.M., Ling M.R., Langley R., Breneman D., Rafal E. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy. J Am Acad Dermatol. 2001;44(1):S28–38. https://doi.org/10.1067/mjd.2001.109810.; Paller A., Eichenfield L.F., Leung D.Y.M., Steward D., Appell M. A 12-week study of tacrolimus oint ment for the treatment of atopic dermatitis in pediatric patients. J Am Acad Dermatol. 2001;44(1):S47–57. https://doi.org/10.1067/mjd.2001.109813.; Soter N.A., Fleischer A.B., Webster G.F., Monroe E., Lawrence I. Tacrolimus ointment for the treat ment of atopic dermatitis in adult patients: part II, safety. J Am Acad Dermatol. 2001;44(1):S39–46. https://doi.org/10.1067/mjd.2001.109817.; Frankel H.C., Qureshi A.A. Comparative Effectiveness of Topical Calcineurin Inhibitors in Adult Patients with Atopic Dermatitis. Am J Clin Dermatol. 2012;13(2):113–123. https://doi.org/10.2165/11597780-000000000-00000.; Reitamo S., Rissanen J., Remitz A., Granlund H., Erkko P., Elg P. et al. Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial. J Invest Dermatol. 1998;111(3):396–398. https://doi.org/10.1046/j.1523-1747.1998.00323.x.; Undre N.A., Moloney F.J., Ahmadi S., Stevenson P., Murphy G.M. Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis British J Dermatol. 2009;160(3):665–669. https://doi.org/10.1111/j.1365-2133.2008.08974.x.; Eichenfield L.F., Tom W.L., Berger T.G., Krol A., Paller A.S., Schwarzenberger K. et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71(1):116–132. https://doi.org/10.1016/j.jaad.2014.03.023.; Wollenberg A., Barbarot S., Bieber T., Christen-Zaech S., Deleuran M., Fink-Wagner A. et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018;32(5):657–682. https://doi.org/10.1111/jdv.14891.; Sidbury R., Davis D.M., Cohen D.E., Cordoro K.M., Berger T.G., Bergman J.N. et al. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014;71(2):327–349. https://doi.org/10.1016/j.jaad.2014.03.030.; Nakahara T., Koga T., Fukagawa S., Uchi H., Furue M. Intermittent topical corticosteroid/tacrolimus sequential therapy improves lichenification and chronic papules more efficiently than intermittent topical corticosteroid/emollient sequential therapy in patients with atopic dermatitis. J Dermatol. 2004;31(7):524–528. https://doi.org/10.1111/j.1346-8138.2004.tb00548.x.; Кубанова А.А., Кубанов А.А., Самцов А.В., Аравийская Е.Р. Федеральные клинические рекомендации. Дерматовенерология 2015: Болезни кожи. Инфекции, передаваемые половым путем. 5-е изд., перераб. и доп. М.: Деловой экспресс; 2016. 748 с. Режим доступа: https://www.cnikvi.ru/docs/2335_maket_30.pdf.; Sugarman J.H., Fleischer A.B., Feldman S.R. Off-label prescribing in the treatment of dermatologic disease. J Am Acad Dermatol. 2002;47(2):217–223. https://doi.org/10.1067/mjd.2002.120469.; Gupta A.K., Versteeg S.G. Topical treatment of facial sebor rheic dermatitis: a systematic review. Am J Clin Dermatol. 2017;18(2):193–213. https://doi.org/10.1007/s40257-016-0232-2.; Kuhn A., Gensch K., Haust M., Schneider S.W., Bonsmann G., GaebeleinWissing N. et al. Efficacy of tacrolimus 0,1% ointment in cutaneous lupus erythematosus: a multicenter, randomized, double-blind, vehicle-controlled trial. J Am Acad Dermatol. 2011;65(1):54–64. https://doi.org/10.1016/j.jaad.2010.03.037.; Saripalli Y.V., Gadzia J.E., Belsito D.V. Tacrolimus ointment 0.1% in the treatment of nickel-induced allergic contact derma titis. J Am Acad Dermatol. 2003;49(3):477–482. https://doi.org/10.1067/s0190-9622(03)01826-7.; Pacor M.L., Di Lorenzo G., Martinelli N., Mansueto P., Friso S., Pellitteri M.E. et al. Tacrolimus oint ment in nickel sulphate-induced steroid-resistant allergic con tact dermatitis. Allergy Asthma Proc. 2006;27(6):527–531. https://doi.org/10.2500/aap.2006.27.2915.; Belsito D., Wilson D.C., Warshaw E., Fowler J., Ehrlich A., Anderson B. et al. A prospective ran domized clinical trial of 0.1% tacrolimus ointment in a model of chronic allergic contact dermatitis. J Am Acad Dermatol. 2006;55(1):40–46. https://doi.org/10.1016/j.jaad.2006.03.025.; Katsarou A., Makris M., Papagiannaki K., Lagogianni E., Tagka A., Kalogeromitros D. Tacrolimus 0.1% vs mometasone furoate topical treatment in allergic contact hand eczema: a prospective randomized clinical study. Eur J Dermatol. 2012;22(2):192–196. https://doi.org/10.1684/ejd.2011.1615.; Alomar A., Puig L., Gallardo C.M., Valenzuela N. Topical tacro limus 0.1% ointment (Protopic®) reverses nickel contact der matitis elicited by allergen challenge to a similar degree to mometasone furoate 0.1% with greater suppression of late erythema. Contact Dermatitis. 2003;49(4):185–188. https://doi.org/10.1111/j.0105-1873.2003.0217.x.; Müller G.G., José N.K., de Castro R.S. Topical tacrolimus 0,03% as sole therapy in vernal keratoconjunctivitis: a randomized double-masked study. Eye Contact Lens. 2014;40(2):79–83. https://doi.org/10.1097/ICL.0000000000000001.; Матушевская Е.В., Коцарева О.Д., Матушевская Ю.И., Свирщевская Е.В. Поддерживающая терапия при атопическом дерматите у взрослых и детей. Клиническая дерматология и венерология. 2017;16(4):14–20. https://doi.org/10.17116/klinderma201716414-20.; Cavalié M., Ezzedine K., Fontas E., Montaudié H., Castela E., Bahadoran P. et al. Maintenance therapy of adult vitiligo with 0,1% tacrolimus ointment: a randomized, double blind, placebo-controlled study. J Invest Dermatol. 2015;135(4):970–974. https://doi.org/10.1038/jid.2014.527.; Luger T., Boguniewicz M., Carr W., Cork M., Deleuran M., Eichenfield L. et al. Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants. Pediatr Allergy Immunol. 2015;26(4):306–315. https://doi.org/10.1111/pai.12331.
-
17Academic Journal
Authors: Yu. M. Naboka
Source: Clinical pharmacy; Vol. 23 No. 4 (2019); 24-29
Клиническая фармация; Том 23 № 4 (2019); 24-29
Клінічна фармація; Том 23 № 4 (2019); 24-29Subject Terms: «Артритан», 'Arthritan', щури, 57.084.1, 3. Good health, carrageenin inflammation, rats, каррагениновое воспаление, 03 medical and health sciences, фитокомпозиция, 0302 clinical medicine, противовоспалительное действие, phytocomposition, anti-inflammatory effect, 615.322], карагенінове запалення, фітокомпозиція, УДК [615.276, UDC [615.276, крысы, протизапальна дія
File Description: application/pdf
-
18Academic Journal
Authors: Drogovoz, S., Kononenko, A., Shchokina, K., Belik, G., Shtroblya, A.
Source: Український біофармацевтичний журнал; № 4(57) (2018); 4-8
Ukraïns’kij bìofarmacevtičnij žurnal; № 4(57) (2018); 4-8
Украинский биофармацевтический журнал; № 4(57) (2018); 4-8Subject Terms: псориаз, кератиноциты, карбокситерапия, антипролиферативное, противовоспалительное действие, 03 medical and health sciences, 0302 clinical medicine, UDC: 615.262.1:615.015.4:615.032:615.5, psoriasis, keratinocytes, carboxytherapy, antiproliferative, anti-inflammatory effect, псоріаз, кератиноцити, карбокситерапія, антипроліферативна, протизапальна дія, УДК: 615.262.1:615.015.4:615.032:615.5, 3. Good health
File Description: application/pdf
-
19Academic Journal
Development of Green Production TECHNOLOGY and Research of Harpagophytum Procumbens Root Dry Extract
Source: ScienceRise: Pharmaceutical Science
Subject Terms: гарпагозид, Harpagophytum procumbens, standardization parameters, analgesic and anti-inflammatory activities, гарпагофітум лежачий, параметри стандартизації, анальгетична та протизапальна дії, параметры стандартизации, анальгетическое и противовоспалительное действие, harpagoside, Indonesia, гарпагофитум лежачий
File Description: application/pdf
-
20Academic Journal
Authors: Butko, Y. (Yaroslava), Tkachova, O. (Oksana), Tishakova, T. (Tetyana), Gordienko, A. (Anatoly), Bondariev, Y. (Yevhen)
Source: ScienceRise: Pharmaceutical Science
Subject Terms: chemical wounds, dexpanthenol, ceramides, propolis, lidocaine, wound-healing effect, anti-inflammatory effect, healing area, cream, декспантенол, прополіс, лідокаїн, ранозагоювальна дія, протизапальна дія, площа загоєння, крем, мазь, химические раны, керамиды, прополис, лидокаин, Indonesia, ointment, хімічні рани, кераміди, ранозаживляющее действие, противовоспалительное действие, площадь заживления
File Description: application/pdf